Tesla
TSLA
NVIDIA
NVDA
Palantir
PLTR
4
Apple
AAPL
5
Gorilla Technology
GRRR
US Stock MarketDetailed Quotes
EOLS Evolus
- 12.710
- +0.030+0.24%
Close Mar 11 16:00 ET
- 12.710
- 0.0000.00%
Post 16:20 ET
808.19MMarket Cap-15.69P/E (TTM)
12.860High12.040Low798.23KVolume12.600Open12.680Pre Close10.02MTurnover1.54%Turnover RatioLossP/E (Static)63.59MShares17.82052wk High146.09P/B660.54MFloat Cap9.25052wk Low--Dividend TTM51.97MShs Float39.500Historical High--Div YieldTTM6.47%Amplitude2.850Historical Low12.556Avg Price1Lot Size
About Evolus Company
Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. It offers products under the brand of Jeuveau. The company was founded by Scott Cannizzaro in November 2012 and is headquartered in Newport Beach, CA.
Company Profile
SymbolEOLS
Company NameEvolus
Listing DateFeb 8, 2018
Issue Price12.00
Founded2012
CEOMr. David Moatazedi
MarketNASDAQ
Employees332
Fiscal Year Ends12-31
Address520 Newport Center Drive,Suite 1200
CityNewport Beach
ProvinceCalifornia
CountryUnited States of America
Zip Code92660
Phone1-949-284-4555
Websitehttp://www.evolus.com
Company Executives
- Name
- Position
- Salary
- David Moatazedi
- Director, President and Chief Executive Officer
- 11.24M
- Dr. Rui Avelar, M.D.
- Head of Research and Development and Chief Medical Officer
- 2.93M
- Sandra Beaver
- Chief Financial Officer
- 2.46M
- Tomoko Yamagishi-Dressler
- Chief Marketing Officer
- --
- Vikram Malik
- Chairman of the Board
- 271.03K
- Simone Blank
- Independent Director
- 235.03K
- Karah Parschauer
- Independent Director
- 249.03K
- Brady Stewart
- Independent Director
- 222.03K
- David N. Gill
- Independent Director
- 256.03K
- Albert G. White, III
- Independent Director
- --